ADD ANYTHING HERE OR JUST REMOVE IT…
Wrong menu selected
Acarix Acarix
  • Product

    Background

    • What is Coronary Artery Disease (CAD)?
    • Diagnosing CAD

    About the product

    • The CADScor® System
    • How does it work
  • Resources

    Testimonials

    • HCP stories
    • Patient stories

    References

    • Clinical Studies
    • Questionnaire
    • Downloads (US)
    • Downloads (EU)
    • Education

    Support

    • Training
    • FAQ
    • Reimbursement

    Physician Locator

    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Rights Issue/Warrant Program
    • Previous Rights Issue
    • Investor Presentations
  • Company

    Who we are

    • About Acarix
    • leadership
    • Join the team

    Get in touch

    • Contact us
    • Investigator Initiated Study
  • News
    • Press
    • Events
    • Social Media
Account
Search
Book a Demo
Acarix Acarix
Book a demo
Menu
author-avatar acarix
Press
August 6, 2024
14 Nov 2019

Acarix AB (publ) publishes Interim Report, January – September 2019

Malmö, November 14, 2019 Acarix finalized a rights issue to finance further market expansion In September we announced a rights i...
Continue reading
author-avatar acarix
Press
August 6, 2024
14 Nov 2019

Acarix AB (publ) publicerar delårsrapport, januari – september 2019

Malmö den 14 november 2019 Acarix genomförde en företrädesemission för fortsatt marknadsexpansion Nyligen aviserade vi en nyemiss...
Continue reading
author-avatar acarix
Press
August 6, 2024
30 Oct 2019

Acarix announce final outcome in rights issue

Press release Malmö, 30 October 2019 Inside informationAcarix AB Acarix announce final outcome in rights issue Acarix AB ("Ac...
Continue reading
author-avatar acarix
Press
August 6, 2024
30 Oct 2019

Acarix offentliggör slutgiltigt utfall i företrädesemission

Pressmeddelande  Malmö, 30 oktober 2019 InsiderinformationAcarix AB Acarix offentliggör slutgiltigt utfall i företrädesemission Ac...
Continue reading
author-avatar acarix
Press
August 6, 2024
09 Oct 2019

Idag inleds teckningsperioden i Acarix företrädesemission

Pressmeddelande  Malmö, 9 oktober 2019 Idag inleds teckningsperioden i Acarix företrädesemission Styrelsen i Acarix AB ("Acari...
Continue reading
author-avatar acarix
Press
August 6, 2024
09 Oct 2019

The subscription period in Acarix’ rights issue commence today

Press release Malmö, 9 October 2019 The subscription period in Acarix' rights issue commence today The board of directors of Ac...
Continue reading
author-avatar acarix
Press
August 6, 2024
30 Sep 2019

Acarix publish EU growth prospectus in connection with rights issue of up to approximately SEK 51.8 million

Press release Malmö, 30 September 2019 Acarix publish EU growth prospectus in connection with rights issue of up to approximately SEK...
Continue reading
author-avatar acarix
Press
August 6, 2024
30 Sep 2019

Acarix offentliggör EU-tillväxtprospekt i samband med företrädesemission om cirka 51,8 MSEK

Pressmeddelande  Malmö, 30 september 2019 Acarix offentliggör EU-tillväxtprospekt i samband med företrädesemission om cirka 51,8 MSEK...
Continue reading
author-avatar acarix
Press
August 6, 2024
25 Sep 2019

Acarix genomför företrädesemission om cirka 51,8 MSEK för att finansiera ökad marknadsexpansion

Pressmeddelande  Malmö, 25 september 2019 Acarix genomför företrädesemission om cirka 51,8 MSEK för att finansiera ökad marknadsexpa...
Continue reading
author-avatar acarix
Press
August 6, 2024
25 Sep 2019

Acarix carries out a rights issue of approximately SEK 51.8 million to finance an increased market expansion

Press release  Malmö, 25 September 2019 Acarix carries out a rights issue of approximately SEK 51.8 million to finance an increased ...
Continue reading
author-avatar acarix
Press
August 6, 2024
16 Aug 2019

Announcement from Acarix’s extra general meeting

Press releaseMalmö August 5, 2019 Announcement from Acarix's extra general meeting The extra general meeting ("EGM") o...
Continue reading
author-avatar acarix
Press
August 6, 2024
16 Aug 2019

Kommuniké från extra bolagsstämma i Acarix

Press releaseMalmö Augusti 16, 2019 Kommuniké från extra bolagsstämma i Acarix Extra bolagsstämman i Acarix AB ("Acarix" el...
Continue reading
  • «
  • ‹
  • 27
  • 28
  • 29
  • 30
  • 31
  • ›
  • »
Acarix AB
Jungmansgatan 12
211 19 Malmö
SE
[email protected]

Product

Background

  • What is Coronary Artery Disease (CAD)?
  • Diagnosing CAD

About the product

  • The CADScor® System
  • How does it work

Resources

Testimonials

  • HCP stories
  • Patient stories

Support

  • Training
  • FAQ

References

  • Clinical Studies
  • Downloads (US)
  • Downloads (EU)

Investors

  • Corporate Governance
  • General Meetings
  • Financial Reports and Calendar
  • The Acarix Share
  • Rights Issue
  • Investor Presentations

Company

Who we are

  • About Acarix
  • Management
  • Join the team

Get in touch

  • Contact us
  • LinkedIn
  • Twitter

News

  • Press
  • Events
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy

Acarix, 2025. All rights reserved V5

  • Products
    • Background
    • What is Coronary Artery Disease
    • Diagnosing CAD
    • About the product
    • The Cadscor System
    • How Does it Work
  • Resources
    • Testimonial
    • HCP Stories
    • Patients Stories
    • References
    • Clinical Studies
    • Downloads (US)
    • Downloads (EU)
    • Support
    • Training
    • Faq
    • Reimbursement
    • Physician Locator
    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Right Issue
    • Previous Rights Issue
    • Investor Presentations
  • Company
    • Who we are
    • About Acarix
    • Leadership
    • Join The Team
    • Get in touch
    • Contact Us
    • Investigator Initiated Study
  • News
    • News
    • Press
    • Events
    • Socialmedia
Start typing to see products you are looking for.